GMO Beyond China ETF (NYSEARCA:BCHI) Short Interest Up 487.6% in January

GMO Beyond China ETF (NYSEARCA:BCHI) saw a large growth in short interest in the month of January. As of January 30th, there was short interest totaling 82,944 shares, a growth of 487.6% from the January 15th total of 14,115 shares. Currently, 20.7% of the shares of the stock are sold short. Based on an average trading volume of 4,471 shares, the short-interest ratio is presently 18.6 days. Based on an average trading volume of 4,471 shares, the short-interest ratio is presently 18.6 days. Currently, 20.7% of the shares of the stock are sold short.

GMO Beyond China ETF Price Performance

Shares of GMO Beyond China ETF stock traded down $0.11 during trading on Thursday, hitting $34.30. 9,099 shares of the company’s stock traded hands, compared to its average volume of 5,169. The company has a market cap of $13.72 million, a PE ratio of 14.75 and a beta of 1.37. The firm’s fifty day moving average price is $31.71 and its 200 day moving average price is $30.12. GMO Beyond China ETF has a twelve month low of $21.81 and a twelve month high of $34.92.

Institutional Investors Weigh In On GMO Beyond China ETF

A hedge fund recently bought a new stake in GMO Beyond China ETF stock. Lazard Asset Management LLC bought a new position in shares of GMO Beyond China ETF (NYSEARCA:BCHI) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 20,851 shares of the company’s stock, valued at approximately $570,000. Lazard Asset Management LLC owned 5.21% of GMO Beyond China ETF at the end of the most recent reporting period.

GMO Beyond China ETF Company Profile

The GMO Beyond China ETF (BCHI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed to invest in equity securities of any market capitalization from emerging markets, with the exemption of China. BCHI was launched on Feb 12, 2025 and is issued by GMO.